Marshall Wace, LLP Cardlytics, Inc. Transaction History
Marshall Wace, LLP
- $63.3 Billion
- Q1 2024
A detailed history of Marshall Wace, LLP transactions in Cardlytics, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 762,200 shares of CDLX stock, worth $6.26 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
762,200
Previous 623,350
22.27%
Holding current value
$6.26 Million
Previous $5.74 Million
92.37%
% of portfolio
0.02%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding CDLX
# of Institutions
165Shares Held
35.7MCall Options Held
739KPut Options Held
1.29M-
Cliff Sosin Cas Investment Partners, LLC | New York, Ny6.37MShares$52.3 Million8.28% of portfolio
-
Black Rock Inc. New York, NY2.87MShares$23.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.29MShares$18.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.21MShares$18.2 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY2MShares$16.4 Million2.47% of portfolio
About Cardlytics, Inc.
- Ticker CDLX
- Exchange NASDAQ
- Sector Communication Services
- Industry Advertising Agencies
- Shares Outstandng 32,893,800
- Market Cap $270M
- Description
- Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and var...